BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34973414)

  • 21. Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile.
    Huang KW; Reebye V; Czysz K; Ciriello S; Dorman S; Reccia I; Lai HS; Peng L; Kostomitsopoulos N; Nicholls J; Habib RS; Tomalia DA; Sætrom P; Wilkes E; Cutillas P; Rossi JJ; Habib NA
    Mol Ther Nucleic Acids; 2020 Mar; 19():361-370. PubMed ID: 31877412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.
    Zvintzou E; Lhomme M; Chasapi S; Filou S; Theodoropoulos V; Xapapadaki E; Kontush A; Spyroulias G; Tellis CC; Tselepis AD; Constantinou C; Kypreos KE
    J Lipid Res; 2017 Sep; 58(9):1869-1883. PubMed ID: 28701354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A non-coding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expression.
    Ketharnathan S; Leask M; Boocock J; Phipps-Green AJ; Antony J; O'Sullivan JM; Merriman TR; Horsfield JA
    Hum Mol Genet; 2018 Nov; 27(22):3964-3973. PubMed ID: 30124855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HNF4A Regulates the Formation of Hepatic Progenitor Cells from Human iPSC-Derived Endoderm by Facilitating Efficient Recruitment of RNA Pol II.
    DeLaForest A; Di Furio F; Jing R; Ludwig-Kubinski A; Twaroski K; Urick A; Pulakanti K; Rao S; Duncan SA
    Genes (Basel); 2018 Dec; 10(1):. PubMed ID: 30597922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAF4, a subunit of transcription factor II D, directs promoter occupancy of nuclear receptor HNF4A during post-natal hepatocyte differentiation.
    Alpern D; Langer D; Ballester B; Le Gras S; Romier C; Mengus G; Davidson I
    Elife; 2014 Sep; 3():e03613. PubMed ID: 25209997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between the DNA methylations of POMC, MC4R, and HNF4A and metabolic profiles in the blood of children aged 7-9 years.
    Kwon EJ; You YA; Park B; Ha EH; Kim HS; Park H; Kim YJ
    BMC Pediatr; 2018 Mar; 18(1):121. PubMed ID: 29598821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis.
    Cheng CC; Yang WY; Hsiao MC; Lin KH; Lee HW; Yuh CH
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32545625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
    He Y; Chen L; Chen K; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function.
    Filou S; Lhomme M; Karavia EA; Kalogeropoulou C; Theodoropoulos V; Zvintzou E; Sakellaropoulos GC; Petropoulou PI; Constantinou C; Kontush A; Kypreos KE
    Biochemistry; 2016 Jul; 55(27):3752-62. PubMed ID: 27332083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factors GATA4 and HNF4A control distinct aspects of intestinal homeostasis in conjunction with transcription factor CDX2.
    San Roman AK; Aronson BE; Krasinski SD; Shivdasani RA; Verzi MP
    J Biol Chem; 2015 Jan; 290(3):1850-60. PubMed ID: 25488664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.
    Yazdanyar A; Quan W; Jin W; Jiang XC
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2058-64. PubMed ID: 23846500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The WWOX gene modulates high-density lipoprotein and lipid metabolism.
    Iatan I; Choi HY; Ruel I; Reddy MV; Kil H; Lee J; Odeh MA; Salah Z; Abu-Remaileh M; Weissglas-Volkov D; Nikkola E; Civelek M; Awan Z; Croce CM; Aqeilan RI; Pajukanta P; Aldaz CM; Genest J
    Circ Cardiovasc Genet; 2014 Aug; 7(4):491-504. PubMed ID: 24871327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing.
    Wallerman O; Motallebipour M; Enroth S; Patra K; Bysani MS; Komorowski J; Wadelius C
    Nucleic Acids Res; 2009 Dec; 37(22):7498-508. PubMed ID: 19822575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DGAT1 participates in the effect of HNF4A on hepatic secretion of triglyceride-rich lipoproteins.
    Krapivner S; Iglesias MJ; Silveira A; Tegnér J; Björkegren J; Hamsten A; van't Hooft FM
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):962-7. PubMed ID: 20167659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.
    Gkouskou KK; Ioannou M; Pavlopoulos GA; Georgila K; Siganou A; Nikolaidis G; Kanellis DC; Moore S; Papadakis KA; Kardassis D; Iliopoulos I; McDyer FA; Drakos E; Eliopoulos AG
    Oncogene; 2016 May; 35(19):2496-505. PubMed ID: 26279300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss-of-function mutations in Zn-finger DNA-binding domain of
    Taniguchi H; Fujimoto A; Kono H; Furuta M; Fujita M; Nakagawa H
    Oncotarget; 2018 May; 9(40):26144-26156. PubMed ID: 29899848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Long Noncoding RNA Hepatocyte Nuclear Factor 4
    Wang P; Chen S; Wang Y; Wang X; Yan L; Yang K; Zhong XB; Han S; Zhang L
    Drug Metab Dispos; 2021 May; 49(5):361-368. PubMed ID: 33674270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hepatocyte nuclear factor 4A(
    Vlachopapadopoulou EA; Dikaiakou E; Fotiadou A; Sifianou P; Tatsi EB; Sertedaki A; Kanaka-Gantenbein C; Michalacos S
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):527-530. PubMed ID: 33031054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.